Related Experiment Video
Updated: Oct 11, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India
Gopal K Bohra1, Abhishek Purohit1, Deepak Kumar1
1Department of Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Insights
COVID-19 severity is linked to coagulation and inflammation. Key indicators like D-dimer and hs-CRP predict mortality, highlighting their role in disease progression and patient outcomes.
Area of Science:
- Medical Research
- Pathophysiology
- Clinical Diagnostics
Background:
- Understanding COVID-19 pathogenesis requires investigating the interplay between coagulation and inflammation.
- Previous studies suggest a complex relationship between these mediators and disease development.
Purpose of the Study:
- To analyze coagulation parameters and inflammatory markers in COVID-19 patients.
- To correlate these markers with disease severity and patient outcomes.
Main Methods:
- A single-center observational cross-sectional study involving 230 COVID-19 patients.
- Measurement of procoagulants (PT, APTT, D-dimer, LA, fibrinogen, F-VIII), anticoagulants (PC, PS, antithrombin), and inflammatory markers (IL-6, hs-CRP).
Main Results:
- Disease severity correlated with increased procoagulant and inflammatory markers (PT, APTT, D-dimer, fibrinogen, F-VIII, IL-6, hs-CRP).
- Anticoagulant levels (PC, Antithrombin) decreased with increasing disease severity.
- Advanced age, high D-dimer, and high hs-CRP were independent predictors of mortality.
Conclusions:
- Elevated coagulation and inflammatory markers are associated with COVID-19 severity.
- Specific markers (Age, D-dimer, IL-6, hs-CRP, APTT, fibrinogen, Factor VIII) are significantly higher in moderate to severe cases.
- Advanced age, high D-dimer, and high hs-CRP predict poor outcomes in COVID-19 patients.
Background:
The understanding of pathogenesis is necessary for the development of effective treatment for COVID-19. Various studies have postulated that there is a complex interplay of mediators of coagulation and inflammation responsible for the pathogenesis of COVID-19. We did this study on coagulation parameters and inflammatory markers and their effect on outcome in patients with COVID-19.
Methods:
This was a single centre observational cross-sectional study. Procoagulants [Prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer, lupus anticoagulant (LA), fibrinogen, factor-VIII (F-VIII)]; anticoagulants [protein-C (PC), protein-S (PS), antithrombin] and inflammatory markers [interleukin-6 (IL-6) and highly sensitive - C-reactive protein (hs-CRP)] were measured at the time of hospitalization and correlated with the severity of the disease.
Results:
A total of 230 patients were enrolled, of which 61.3%, 20.0%, and 18.7% had asymptomatic/ mild, moderate, or severe disease, respectively. COVID-19 disease severity was associated with rising trends with coagulation parameters (PT, APTT, D-Dimer; p value 0.01, <0.0001, <0.0001, respectively). Falling trends of anticoagulant (PC, Antithrombin; p value <0.0001, 0.003 respectively) and rising trends of procoagulant (fibrinogen, F-VIII; p value 0.004, <0.0001 respectively) were observed with increasing COVID-19 disease severity. Multivariate logistic regression analysis found that advanced age, high D-Dimer, and high hs-CRP (p value 0.035, 0.018, <0.0001 respectively) were independent predictors of mortality in COVID-19. Procoagulant parameters (D-dimer, APTT, Factor VIII) were positively correlated with anticoagulant parameters (PC and PS) and inflammatory parameters (hs-CRP).
Conclusion:
This study revealed increased levels of coagulation and inflammatory parameters, which correlated with the severity of COVID-19. Age, D-dimer, IL-6, hs-CRP, APTT, fibrinogen, and Factor VIII were significantly higher in patients with moderate and severe disease as compared to asymptomatic/mild disease. Advanced age, high D-dimer, and high hs-CRP were significantly associated with poor outcomes.
Related Concept Videos
Coagulation
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis III: Interprofessional Care
